Log In
BCIQ
Print this Print this
 

buprenorphine buccal film (Belbuca)

Also known as: BEMA Buprenorphine (EN3409) (formerly BEMA LA)

  Manage Alerts
Collapse Summary General Information
Company BioDelivery Sciences International Inc.
DescriptionBuprenorphine formulated with the BEMA transmucosal delivery system
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of ActionMu opioid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat chronic pain; Treat moderate to severe chronic pain; Treat pain
Regulatory Designation
PartnerEndo International plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$180.0M

$30.0M

$150.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/09/2012

$180.0M

$30.0M

$150.0M

Get a free BioCentury trial today